- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | - | SEC Filings | ||
| NEONC TECHNOLOGIES Aktie jetzt für 0€ handeln | |||||
| Mo | 24/7 Market News and NeOnc Technology: NeOnc Is Putting Two Brain Cancer Programs on the Global Stage | 1 | GlobeNewswire (USA) | ||
| Fr | 24/7 Market News and NeOnc Technology: NeOnc's Ambitious Brain Cancer Plans are Setting the Stage | 1 | GlobeNewswire (USA) | ||
| 26.10. | 24/7 Market News and NeOnc Technology: NeOnc Targets Major Brain Cancer Trial Expansion with 500 Patients Across 30 Hospitals in Three Countries | 2 | GlobeNewswire (USA) | ||
| 23.10. | 24/7 Market News and NeOnc Technology: NeOnc Breaks Through Key Levels, as Brain-Cancer Stock's Catalysts Continue | 1 | GlobeNewswire (USA) | ||
| 22.10. | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 22.10. | 24/7 Market News and NeOnc Technology: NeOnc Heads to Fox Business as Brain Cancer Milestones Put Its Mission in the Spotlight | 4 | GlobeNewswire (USA) | ||
| 21.10. | WallStreet-PR: NeOnc's Brain Cancer Efforts Bring Hope as FDA Meeting Approaches | 513 | Newsfile | Compassionate care for children in Abu Dhabi, a new research MoU and a senior banking appointment add momentum to NeOnc's development storyHouston, Texas--(Newsfile Corp. - October 21, 2026) - As NeOnc... ► Artikel lesen | |
| 21.10. | 24/7 Market News and NeOnc Technology: NeOnc Deepens Abu Dhabi Research Ties as Its Brain Cancer Story Moves Forward | 3 | GlobeNewswire (USA) | ||
| 20.10. | 24/7 Market News and NeOnc Technology: Forget the Ugly Sweaters and Ugly Charts, NeOnc is Ready for Catalyst Season | 1 | GlobeNewswire (USA) | ||
| 16.10. | WallStreet-PR: NeOnc's Most Challenging Test Yet: Compassionate-Use Update Puts NEO100's Potential in Focus | 699 | Newsfile | Pediatric Case, Abu Dhabi Expansion and Board Appointment Highlight a Broader Development StrategyHouston, Texas--(Newsfile Corp. - October 16, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) is... ► Artikel lesen | |
| 16.10. | 24/7 Market News and NeOnc Technology: NeOnc's Boldest Test Yet: Child's Early Improvement Puts NEO100 in the Spotlight with Compassionate-Use Milestone | 2 | GlobeNewswire (USA) | ||
| 16.10. | NeOnc Technologies Holdings, Inc.: NeOnc Reports Early Clinical Improvement in First Child Treated with NEO100 Under Compassionate Use in Abu Dhabi | 4 | GlobeNewswire (USA) | ||
| 15.10. | NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K, Current Report | 2 | SEC Filings | ||
| 15.10. | 24/7 Market News and NeOnc Technology: UAE Banking Heavyweight Joins NeOnc as Global Brain-Cancer Drug Development Advances | 2 | GlobeNewswire (USA) | ||
| 14.10. | 24/7 Market News and NeOnc Technology: NeOnc Strengthens Boardroom Firepower as Abu Dhabi Opens a New Path for Brain Cancer Drug Development | 1 | GlobeNewswire (USA) | ||
| 14.10. | NeOnc Technologies Holdings, Inc.: NeOnc Technologies Appoints Ali Alabedin to Its Board of Directors | 3 | GlobeNewswire (USA) | ||
| 07.10. | 24/7 Market News and NeOnc Technology: NeOnc among Names with 2026 Breakthroughs that Offer New Hope in the Fight Against Cancer | 2 | GlobeNewswire (USA) | ||
| 06.10. | Investors Tape and NeOnc: NeOnc's FDA Catalyst Run Could Give NTHI a Serious Jolt | 1 | GlobeNewswire (USA) | ||
| 29.09. | Investors Tape and NeOnc: NeOnc's Powerful Brain Cancer Pipeline Advances | 1 | GlobeNewswire (USA) |
1 2 3 4 5 Weiter >>
85 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVAVAX | 9,130 | +5,55 % | Novavax: Großaktionär verkauft - was jetzt wichtig ist | ||
| INOVIO PHARMACEUTICALS | 1,422 | -3,85 % | Aktien New York Ausblick: Erholungsversuch vor US-Zwischenwahlen | NEW YORK (dpa-AFX) - Nach den herben Verlusten vom Freitag und vor den am Dienstag anstehenden Zwischenwahlen in den USA dürften die US-Börsen am Montag einen Erholungsversuch starten. Im Anlegerfokus... ► Artikel lesen | |
| INFLARX | 1,237 | -14,28 % | InflaRx rutscht ab: Warum die Kidney-Week-Fantasie verpufft | ||
| INTELLIA THERAPEUTICS | 10,780 | +1,70 % | Intellia schließt Rekrutierung für Phase-3-Studie zur ATTRv-PN-Therapie ab | ||
| EDITAS MEDICINE | 2,380 | +1,71 % | Editas Medicine, Inc.: Editas Medicine Receives Approval to Initiate First-In-Human Clinical Trial of EDIT-401 in Patients with Hyperlipidemia | Phase 1/2 clinical trial of EDIT-401 cleared to initiate dosing in patients who require additional LDL-C lowering Company remains on track to begin patient dosing this year and report initial safety... ► Artikel lesen | |
| BIOCRYST PHARMACEUTICALS | 7,746 | +0,75 % | BioCryst Q3 2026 slides: HAE portfolio drives 70% profit jump | ||
| NUREXONE BIOLOGIC | 0,328 | +0,92 % | 3 Datenpakete vor dem ersten Patienten: Wie NurExone ExoPTEN auf die Klinik vorbereitet | ||
| BIOMARIN PHARMACEUTICAL | 50,76 | +2,05 % | BioMarin-Aktie: Ein Kauf vor 2027 könnte sich lohnen | Die BioMarin-Aktie bietet nach einem deutlichen Kursrückgang und einer inzwischen günstigen Bewertung wieder Chancen für kurz- und langfristig orientierte Anleger. Drei anstehende FDA-Entscheidungen... ► Artikel lesen | |
| ABIVAX | 78,85 | -0,32 % | EQS-News: ABIVAX: Abivax to Participate in Upcoming Fall Investor Conferences | EQS-News: ABIVAX
/ Key word(s): Conference
Abivax to Participate in Upcoming Fall Investor Conferences
02.11.2026 / 22:05 CET/CEST
The issuer is solely responsible for... ► Artikel lesen | |
| GERON | 0,890 | +6,43 % | XFRA GON: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| IBIO | 0,733 | +0,34 % | iBio, Inc.: iBio Reports Fiscal Year 2026 Financial Results and Provides Corporate Update | SAN DIEGO, Aug. 28, 2026 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ: IBIO), a clinical-stage biotechnology company developing long-acting antibody therapeutics for obesity, cardiometabolic and cardiopulmonary... ► Artikel lesen | |
| IMMUNITYBIO | 7,490 | +0,94 % | ImmunityBio, Inc.: ImmunityBio Announces First Patients in Europe Treated with ANKTIVA Plus BCG for BCG-unresponsive Non-Muscle Invasive Bladder Cancer with Carcinoma in Situ | First patients treated in Germany and Austria, with commercial support from Accord Healthcare
Treatment milestone follows European Commission's February 2026 conditional marketing authorization... ► Artikel lesen | |
| IMMATICS | 6,265 | -0,95 % | Immatics Presents Clinical Activity of IMA402 PRAME Bispecific and IMA203CD8 PRAME Cell Therapy across Advanced Solid Tumors in Two Oral Presentations at 2026 ESMO Annual Meeting | IMA402 PRAME bispecific continues to demonstrate encouraging anti-tumor activity in multiple indications, alongside a favorable safety profileIMA402 achieved a cORR of 32%, 12.5 months median DOR and... ► Artikel lesen | |
| MYRIAD GENETICS | 5,352 | +0,26 % | Labcorp To Buy Myriad Genetics' Prenatal Testing Business For $210 Mln | WASHINGTON (dpa-AFX) - Laboratory services provider LabCorp Holdings Inc. (LH) announced on Tuesday that it has agreed to acquire the Prenatal Health testing business of molecular diagnostics... ► Artikel lesen | |
| MANNKIND | 3,473 | +4,20 % | MannKind and Rose Pharma Inc Enter Licensing and Collaboration Agreement to Develop an Inhaled Rapid-Acting, Short-Duration GLP-1 for Weight Management | Collaboration combines Rose Pharma investigational rapid-acting GLP-1 receptor agonist with MannKind's Technosphere- inhalation technologyMannKind to receive an equity interest and potential royalties... ► Artikel lesen |
Das Unternehmen NEONC TECHNOLOGIES HOLDINGS INC kann der Branche Biotechnologie zugeordnet werden. Der aktuelle Kurs liegt bei 3,080 Euro und damit +0,33 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NEONC TECHNOLOGIES HOLDINGS INC finden Sie auf Wallstreet Online.